Clinical Trial Update: A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC) [Phase 2]

View source ↗

Summary

A Phase 2 study comparing a dose-titration regimen of fulvestrant to the approved dosing in postmenopausal women with hormone-responsive advanced breast cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN